Award
NIH Reporter #5U54CA283759-04
University of Pennsylvania Patient-derived Xenograft Development and Trials Center
Recipient
University of Pennsylvania
Award Amount
$1,062,215.00
Ceiling
$1,062,215.00
Awarded
August 18, 2026
Identifier
5U54CA283759-04
Award for research on AML and ovarian cancers using patient-derived xenograft models to test new therapies, funded by the National Cancer Institute at University of Pennsylvania.
Description
This project involves research on human malignancies, specifically AML and ovarian cancers, utilizing patient-derived xenograft models to test new therapies. The project is funded by the National Cancer Institute and involves multiple cores and projects focusing on translational cancer research.